Dopamine and Parkinson's disease: is the killer in the house?

被引：15
|
作者：
Chesselet, MF [1 ]
机构：
[1] Univ Calif Los Angeles, Dept Neurol, Geffen Sch Med, Los Angeles, CA 90024 USA
来源：
MOLECULAR PSYCHIATRY | 2003年 / 8卷 / 04期
关键词：
D O I：
10.1038/sj.mp.4001289
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：369 / 370
页数：2
相关论文
共 50 条
  • [21] Are Dopamine Agonists Neuroprotective in Parkinson′s Disease?
    乐卫东
    J Jankovic
    JournalofNanjingMedicalUniversity, 2002, (01) : 40 - 48
  • [22] Choosing a dopamine agonist in Parkinson's disease
    Bogucki, Andrzej
    Gaios, Agata
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2007, 41 (02) : S14 - S21
  • [23] Dopamine dysregulation syndrome in Parkinson's disease
    Borg, M.
    Bayreuther, C.
    REVUE NEUROLOGIQUE, 2008, 164 (04) : 310 - 321
  • [24] α-Synuclein and dopamine at the crossroads of Parkinson's disease
    Venda, Lara Lourenco
    Cragg, Stephanie J.
    Buchman, Vladimir L.
    Wade-Martins, Richard
    TRENDS IN NEUROSCIENCES, 2010, 33 (12) : 559 - 568
  • [25] Imaging dopamine transporters in Parkinson's disease
    Brooks, David J.
    BIOMARKERS IN MEDICINE, 2010, 4 (05) : 651 - 660
  • [26] Dopamine dysregulation syndrome in Parkinson's disease
    Evans, AH
    Lees, AJ
    CURRENT OPINION IN NEUROLOGY, 2004, 17 (04) : 393 - 398
  • [27] Endogenous dopamine release in Parkinson's disease
    Rinne, JO
    LANCET NEUROLOGY, 2003, 2 (08): : 460 - 461
  • [28] Choosing dopamine agonists in Parkinson's disease
    Jankovic, J
    Tan, EK
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (05) : 247 - 253
  • [29] Dopamine/glutamate interactions in Parkinson's disease
    Lange, KW
    Kornhuber, J
    Riederer, P
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (04): : 393 - 400
  • [30] Dopamine neurotransmission, Parkinson's disease and SPET
    Costa, DC
    Lees, AJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2002, 29 (01) : 163 - 163
12345